Cargando…
Oridonin Attenuates Thioacetamide-Induced Osteoclastogenesis Through MAPK/NF-κB Pathway and Thioacetamide-Inhibited Osteoblastogenesis Through BMP-2/RUNX2 Pathway
Osteoporosis, an age-related metabolic bone disease, is mainly caused by an imbalance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. At present, there are many osteoporosis drugs that can promote bone formation or inhibit bone resorption. However, there were few...
Autores principales: | Jin, XiaoLi, Xu, Jia, Yang, Fanfan, Chen, Jin, Luo, Feng, Xu, Bin, Xu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198936/ https://www.ncbi.nlm.nih.gov/pubmed/37032340 http://dx.doi.org/10.1007/s00223-023-01080-5 |
Ejemplares similares
-
Acute bone damage through liver-bone axis induced by thioacetamide in rats
por: Jin, Xiaoli, et al.
Publicado: (2022) -
Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways
por: Jin, XiaoLi, et al.
Publicado: (2022) -
Icariin attenuates thioacetamide-induced bone loss via the RANKL-p38/ERK-NFAT signaling pathway
por: Cheng, Linyan, et al.
Publicado: (2022) -
Collagen Peptide Upregulates Osteoblastogenesis from Bone Marrow Mesenchymal Stem Cells through MAPK- Runx2
por: Elango, Jeevithan, et al.
Publicado: (2019) -
UBAP2 plays a role in bone homeostasis through the regulation of osteoblastogenesis and osteoclastogenesis
por: Kim, Jeonghyun, et al.
Publicado: (2023)